News

July 13, 2011

Experience the Latest “Spring” Product Innovations at AADE Booth 1910

Tirat Carmel, Israel – July 11, 2011 – D. Medical Industries Ltd. (NASDAQ: DMED; TASE:DMED;) is pleased to announce that it will offer sampling of its recently U.S. FDA and Health Canada cleared Spring™ Universal Infusion Set, demonstrate its innovative Spring Zone insulin pump and provide a glimpse of its revolutionary Spring Hybrid Patch pump at the American Association of Diabetes Educators Annual Meeting & Exhibition, August 3-5, 2011 in Las Vegas, Booth 1910.

In May 2011, D. Medical received FDA 510(k) clearance to market the Spring Universal Infusion Sets in United States and also a medical device license to market the product in Canada. With mass production already in place, the Company expects to launch the Spring Universal Infusion Sets in the U.S. via multiple distributors over the coming weeks. With respect to Canada, D. Medical has signed a letter of intent with Dex Medical, Canada's largest distributor of diabetes care products, to become exclusive distributor of the Spring Universal Infusion Sets in Canada. While the two companies continue to work toward the signing of a final, definitive agreement, arrangements have been made with Dex Medical to make this important product available for immediate sale and delivery.

Spring Universal Infusion Set

The Spring Universal Infusion Set is compatible with most insulin pumps currently available on the market. Going beyond the minimum requirements of subcutaneous drug delivery, the Spring Universal offers best-in-class features such as a hidden, auto-retractable needle, 360° connector, and smallest one-click, all-in-one inserter.

The core of the Spring Universal Infusion Set is the proprietary Detach-Detect mechanism. In the case the base of the infusion set detaches from the user’s body, a blocking mechanism is triggered which, in turn, creates an occlusion. This evokes an occlusion alarm in an insulin pump. This unique feature enables exceptional reliability for continuously controlled and monitored insulin delivery, providing additional safety and peace of mind - especially for athletes and the parents of pediatric patients.

While nothing can completely eliminate the intrusive feeling of the needle’s insertion in the daily experience of the person with insulin-dependent diabetes, the Spring Universal Infusion Set has a number of features specifically focused on reducing the sensation of pain and discomfort. The sensation of pain is controlled by a combination of factors - the needle thickness (gauge), needle shape, speed of insertion, vibration, and tissue friction. Clocked at 12 meters/second, the all-in-one Spring Universal Infusion Set is currently the fastest available insertion mechanism. Besides the convenience of not having to pre-cock the trigger mechanism, the two springs (one responsible for the insertion, and the other for auto-retraction of the needle) enable lightning speed and accuracy. The base, which is attached to the body prior to insertion, enhances insertion stability, potentially decreasing the possibility of the needle and cannula bending during insertion as well as reducing backfire vibration and sensation. The 28-gauge insertion needle is one of the thinnest available. It features a trocar tip, which allows for the speed and penetration trajectory similar to a shooting arrow. Most of the other insertion mechanisms currently available in the market use the five-edge bevel needle, which is typically recommended for slow intravenous insertion since each one of the five edges creates a more painful incision. In comparison, the trocar tip creates a fast and precise incision allowing for the cannula to smoothly enter the tissue. The insertion sensation is additionally soothed by the fact that the Teflon cannula (rather than metal needle) is pre-lubricated with medical silicone fluid, and the inserter needle is retracted at a spiral trajectory, further reducing the friction.

“This is design innovation with real value to all stakeholders in diabetes management," said Zoe Myers, a long-time insulin pump user and D. Medical's Chief Commercial Officer. "Why is the Spring Universal attractive to every insulin pump user? Ask anyone with insulin-dependent diabetes: Would you rather not look at a needle and would you like the peace of mind of knowing that your insulin is being accurately delivered?"

About D. Medical

D. Medical is a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery. D. Medical has developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient's body, using its proprietary spring-based delivery technology. D. Medical believes that its spring- based delivery mechanism is cost-effective compared to the motor and gear train mechanisms that drive competitive insulin pumps and also allows it to incorporate certain advantageous functions and design features in its insulin pumps. D. Medical has also developed an infusion set for insulin pumps and is focusing its research and development efforts on the development of next generation insulin pumps and a device that will combine a continuous glucose monitoring system and an insulin pump on the same patch. For more information, please visit www.dmedicalindustries.com (corporate) and www.springnow.com (healthcare professionals, patients and caregivers).

Company Contact:

Ksenya Harmelin
Sr Marketing and Communications Manager
Spring Health Solutions
ksenyah@springnow.com
US temporary number until August 15 2011 : 1-206-227-0354
Tel: +972 (0)4 855-0652
www.SpringUniversal.com

Back